Apple, Inc AAPL
S&P 500 ETF Trust SPDR SPY
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

Virtus LifeSci Biotech Clinical Trials ETF Share Price

BBC

PCQ

$43.0303

+$0.81

(1.92%)

Provider: Virtus Category: Health

Overview Returns Holdings Sector Breakdown FAQs

Price Chart

Key Metrics

Expense Ratio info-icon

The expense ratio is how much you pay a mutual fund or ETF per year, expressed as a percent of your investments. It is a measure of the fund's operating costs relative to assets.

0.79%

Volume

This is the total number of shares traded during the most recent trading day.

6.56K

Avg Volume info-icon

This is the average number of shares traded during the most recent 30 days.

Dividend Yield info-icon

This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).

1.47%

Beta

This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.

1.23

52-week Range info-icon

This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

$18.46 L

$48.18 H

$43.0303

About Virtus LifeSci Biotech Clinical Trials ETF, ETF

Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering (lead drug) that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval. more

Provider: VirtusCategory: Health

Returns

Time Frame	BBC	S&P500
1-Week Return	5.83%	0.03%
1-Month Return	-3.39%	-0.06%
3-Month Return	3.94%	10.73%
6-Month Return	7.71%	8.19%
1-Year Return	113.13%	22.21%
3-Year Return	67.77%	70.13%
5-Year Return	-17.25%	73.43%
10-Year Return	120.62%	254.69%

Time Frame	BBC	S&P500
1-Week Return	1,819.43%	1.58%
1-Month Return	-34.27%	-0.73%
3-Month Return	16.97%	51.19%
6-Month Return	16.25%	17.31%
1-Year Return	113.13%	22.21%
3-Year Return	18.82%	19.38%
5-Year Return	-3.72%	11.64%
10-Year Return	8.23%	13.50%

Largest Holdings

Stock name	Ticker	Weight
Erasca Inc	ERAS	3.05%
Tango Therapeutics Inc	TNGX	2.5%
Spyre Therapeutics Inc	SYRE	1.88%
Enliven Therapeutics Inc	ELVN	1.87%
Oruka Therapeutics Inc	ORKA	1.78%
Liquidia Corp	LQDA	1.68%
Rezolute Inc	RZLT	1.68%
Definium Therapeutics Inc	DFTX	1.5%
Revolution Medicines Inc	RVMD	1.48%
Alumis Inc	ALMS	1.42%
Dianthus Therapeutics Inc	DNTH	1.42%
Relay Therapeutics Inc	RLAY	1.39%
Compass Pathways Plc	CMPS	1.32%
GH Research PLC	GHRS	1.24%
Centessa Pharmaceuticals PLC	CNTA	1.17%
Tectonic Therapeutic Inc	TECX	1.16%
AbCellera Biologics Inc	ABCL	1.14%
Edgewise Therapeutics Inc	EWTX	1.12%
Kodiak Sciences Inc	KOD	1.12%
CG oncology Inc	CGON	1.1%
Neurogene Inc	NGNE	1.08%
Corvus Pharmaceuticals Inc	CRVS	1.08%
uniQure NV	QURE	1.08%
Intellia Therapeutics Inc	NTLA	1.07%
Septerna Inc	SEPN	1.05%
Pharvaris NV	PHVS	1.04%
Vir Biotechnology Inc	VIR	1%
MBX Biosciences Inc	MBX	0.98%
Allogene Therapeutics Inc	ALLO	0.97%
Immunovant Inc	IMVT	0.97%
ArriVent Biopharma Inc	AVBP	0.97%
Precigen Inc	PGEN	0.96%
AnaptysBio Inc	ANAB	0.94%
MoonLake Immunotherapeutics	MLTX	0.94%
Xenon Pharmaceuticals Inc	XENE	0.93%
Nuvalent Inc	NUVL	0.92%
Inhibrx Biosciences Inc	INBX	0.92%
Denali Therapeutics Inc	DNLI	0.91%
Rapport Therapeutics Inc	RAPP	0.91%
Apogee Therapeutics Inc	APGE	0.91%
Bicara Therapeutics Inc	BCAX	0.9%
Protagonist Therapeutics Inc	PTGX	0.9%
Tyra Biosciences Inc	TYRA	0.88%
Cytokinetics Inc	CYTK	0.86%
Celldex Therapeutics Inc	CLDX	0.85%
Cullinan Therapeutics Inc	CGEM	0.85%
Nektar Therapeutics	NKTR	0.85%
Arcus Biosciences Inc	RCUS	0.85%
Palvella Therapeutics Inc	PVLA	0.84%
MeiraGTx Holdings plc	MGTX	0.84%
Beam Therapeutics Inc	BEAM	0.84%
Jade Biosciences Inc	JBIO	0.84%
Vaxcyte Inc	PCVX	0.83%
Amylyx Pharmaceuticals Inc	AMLX	0.83%
Monte Rosa Therapeutics Inc	GLUE	0.82%
Ironwood Pharmaceuticals Inc	IRWD	0.79%
Omeros Corp	OMER	0.78%
Biohaven Ltd	BHVN	0.77%
Belite Bio Inc	BLTE	0.76%
Xeris Biopharma Holdings Inc	XERS	0.76%
Taysha Gene Therapies Inc	TSHA	0.75%
Capricor Therapeutics Inc	CAPR	0.75%
Scholar Rock Holding Corp	SRRK	0.75%
Annexon Inc	ANNX	0.74%
Immunome Inc	IMNM	0.73%
Dyne Therapeutics Inc	DYN	0.73%
Kymera Therapeutics Inc	KYMR	0.72%
Praxis Precision Medicines Inc	PRAX	0.72%
Arbutus Biopharma Corp	ABUS	0.71%
Stoke Therapeutics Inc	STOK	0.71%
Immatics NV	IMTX	0.71%
Zymeworks Inc	ZYME	0.71%
Janux Therapeutics Inc	JANX	0.7%
Nurix Therapeutics Inc	NRIX	0.7%
AtaiBeckley Inc	ATAI	0.69%
Celcuity Inc	CELC	0.67%
Ideaya Biosciences Inc	IDYA	0.66%
Replimune Group Inc	REPL	0.66%
Sionna Therapeutics Inc	SION	0.66%
ORIC Pharmaceuticals Inc	ORIC	0.65%
4D Molecular Therapeutics Inc	FDMT	0.64%
Newamsterdam Pharma Co NV	NAMS	0.64%
Prothena Corp PLC	PRTA	0.62%
Monopar Therapeutics Inc	MNPR	0.62%
Rigel Pharmaceuticals Inc	RIGL	0.62%
Rocket Pharmaceuticals Inc	RCKT	0.61%
EyePoint Inc	EYPT	0.61%
Cogent Biosciences Inc	COGT	0.61%
Viking Therapeutics Inc	VKTX	0.6%
Savara Inc	SVRA	0.6%
ProKidney Corp	PROK	0.59%
Summit Therapeutics Inc	SMMT	0.58%
Disc Medicine Inc	IRON	0.58%
Xencor Inc	XNCR	0.57%
Recursion Pharmaceuticals Inc	RXRX	0.57%
CytomX Therapeutics Inc	CTMX	0.56%
Prime Medicine Inc	PRME	0.54%
Vera Therapeutics Inc	VERA	0.53%
Mineralys Therapeutics Inc	MLYS	0.51%
Structure Therapeutics Inc	GPCR	0.51%
Assembly Biosciences Inc	ASMB	0.49%
Maze Therapeutics Inc	MAZE	0.49%
Arvinas Inc	ARVN	0.44%
Bicycle Therapeutics PLC	BCYC	0.43%
Sana Biotechnology Inc	SANA	0.42%
Viridian Therapeutics Inc	VRDN	0.39%
Altimmune Inc	ALT	0.38%
Keros Therapeutics Inc	KROS	0.37%
REGENXBIO Inc	RGNX	0.35%
Zenas Biopharma Inc	ZBIO	0.34%
Lexeo Therapeutics Inc	LXEO	0.34%
Verastem Inc	VSTM	0.32%
Compass Therapeutics Inc	CMPX	0.3%
First Tracks Biotherapeutics Inc	TRAX	0.3%
WaVe Life Sciences Ltd	WVE	0.27%
Invivyd Inc	IVVD	0.27%
Olema Pharmaceuticals Inc	OLMA	0.23%
Fulcrum Therapeutics Inc	FULC	0.21%
Upstream Bio Inc	UPB	0.18%
enGene Therapeutics Inc	ENGN	0.15%
Mereo Biopharma Group PLC	MREO	0.11%
Gossamer Bio Inc	GOSS	0.04%
Cash/Cash equivalents	Cash.Cash.equivalents	0%

Sector Breakdown

Sector	Weight
Health care	100.00%

Discover more

SPDR S&P 500 ETF Trust

Invesco QQQ Trust

Vanguard Total Stock Market Index Fund ETF Shares

iShares Core MSCI EAFE ETF

Vanguard Total Bond Market Index Fund ETF Shares

iShares Bitcoin Trust

Vanguard Growth Index Fund ETF Shares

SPDR® Gold Shares

iShares 20+ Year Treasury Bond ETF

FAQs

What is Virtus LifeSci Biotech Clinical Trials ETF (BBC) ETF share price today?

Virtus LifeSci Biotech Clinical Trials ETF (BBC) share price today is $43.0303.

Can Indians buy Virtus LifeSci Biotech Clinical Trials ETF shares?

Yes, Indians can buy shares of Virtus LifeSci Biotech Clinical Trials ETF (BBC) on Vested. To buy BBC from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.

Can Fractional shares of Virtus LifeSci Biotech Clinical Trials ETF be purchased?

Yes, you can purchase fractional shares of Virtus LifeSci Biotech Clinical Trials ETF (BBC) on Vested. You can start investing in Virtus LifeSci Biotech Clinical Trials ETF (BBC) with a minimum investment of $1.

How to invest in Virtus LifeSci Biotech Clinical Trials ETF shares from India?

Click on Sign Up or Invest in BBC ETF at the top of this page
Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
Transfer USD funds to your US Brokerage account and start investing in Virtus LifeSci Biotech Clinical Trials ETF shares

What is Virtus LifeSci Biotech Clinical Trials ETF's 52-week high and low ETF share price?

The 52-week high price of Virtus LifeSci Biotech Clinical Trials ETF (BBC) is $48.18. The 52-week low price of Virtus LifeSci Biotech Clinical Trials ETF (BBC) is $18.46.

What is Virtus LifeSci Biotech Clinical Trials ETF's ticker or symbol?

The stock symbol (or ticker) of Virtus LifeSci Biotech Clinical Trials ETF is BBC.

Can I set up automatic investments (SIP) in Virtus LifeSci Biotech Clinical Trials ETF shares?

Yes, you can setup SIP in Virtus LifeSci Biotech Clinical Trials ETF shares. Follow the below steps to create the SIP:

Sign up on Vested and complete your KYC for US Stocks
Transfer funds to your US Stocks account
Navigate to BBC tickr page and set up your recurring investment

What is the historical performance of Virtus LifeSci Biotech Clinical Trials ETF ETF?

Here is the historical performance of BBC on the Vested app.

1 Year Return - {X%}
3 Year Return
5 Year
You can also access the top holdings, the expense ratio, and the sector breakdown for Virtus LifeSci Biotech Clinical Trials ETF on Vested.

What is the expense ratio of Virtus LifeSci Biotech Clinical Trials ETF?

The expense ratio of Virtus LifeSci Biotech Clinical Trials ETF (BBC) is 0.79%.